Bank of New York Mellon
ANVS icon

Bank of New York Mellon’s Annovis Bio ANVS Stock Holding History

Bank of New York Mellon’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.8K Hold
15,476
– – ﹤0.01% 4259
2026
Q1 		$34.5K Sell
15,476
-4,582
-23% -$12.6K ﹤0.01% 4158
2025
Q4 		$69.4K Buy
20,058
+1,000
+5% +$3.01K ﹤0.01% 4129
2025
Q3 		$39.5K Hold
19,058
– – ﹤0.01% 4140
2025
Q2 		$41.4K Hold
19,058
– – ﹤0.01% 4093
2025
Q1 		$28.6K Hold
19,058
– – ﹤0.01% 4078
2024
Q4 		$95.9K Sell
19,058
-1
-0% -$7 ﹤0.01% 4035
2024
Q3 		$154K Hold
19,059
– – ﹤0.01% 3958
2024
Q2 		$110K Hold
19,059
– – ﹤0.01% 4023
2024
Q1 		$227K Sell
19,059
-1,646
-8% -$18K ﹤0.01% 3895
2023
Q4 		$387K Sell
20,705
-13,067
-39% -$116K ﹤0.01% 3696
2023
Q3 		$320K Sell
33,772
-355
-1% -$4.39K ﹤0.01% 3774
2023
Q2 		$488K Sell
34,127
-96
-0.3% -$1.36K ﹤0.01% 3611
2023
Q1 		$527K Hold
34,223
– – ﹤0.01% 3471
2022
Q4 		$460K Sell
34,223
-106
-0.3% -$1.32K ﹤0.01% 3579
2022
Q3 		$470K Buy
34,329
+8,837
+35% +$116K ﹤0.01% 3593
2022
Q2 		$289K Sell
25,492
-33
-0.1% -$361 ﹤0.01% 3903
2022
Q1 		$340K Sell
25,525
-5,378
-17% -$77.7K ﹤0.01% 3943
2021
Q4 		$543K Buy
30,903
+4,867
+19% +$125K ﹤0.01% 3756
2021
Q3 		$826K Buy
26,036
+3,868
+17% +$222K ﹤0.01% 3508
2021
Q2 		$1.9M Buy
+22,168
New +$1.02M ﹤0.01% 3013

Other funds holding ANVS

EAM
Empery Asset Management New York $86.5M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FNT
First National Trust Hermitage, Pennsylvania $2.95B AUM 27.19% 1-Year Est. Return
SG
Sherry Group Mountain Home, Arkansas $102M AUM
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
GWM
Greenwich Wealth Management Greenwich, Connecticut $2.74B AUM 36.19% 1-Year Est. Return
WFAG
Wescott Financial Advisory Group Philadelphia, Pennsylvania $1.29B AUM 21.04% 1-Year Est. Return

Bank of New York Mellon's ANVS Position: Q2 2026 in Review

Bank of New York Mellon held its Annovis Bio (ANVS) position steady in Q2 2026 at 15,476 shares worth $28.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4259.

Bank of New York Mellon first reported a position in ANVS in Q2 2021 and has held it in 21 quarters since. The position peaked at $1.9M in Q2 2021. 37 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.

  • Bank of New York Mellon held 15,476 shares of Annovis Bio worth $28.8K as of Q2 2026.
  • Bank of New York Mellon left its Annovis Bio share count unchanged in Q2 2026.
  • Annovis Bio made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #4259 holding.
  • Bank of New York Mellon first reported a position in Annovis Bio in Q2 2021 and has held it in 21 quarters since.
  • Bank of New York Mellon's Annovis Bio position peaked at $1.9M in Q2 2021.
  • 37 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.